lamivudine has been researched along with Aging in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alves Saldanha, S; Battegay, M; Buclin, T; Cavassini, M; Courlet, P; Decosterd, LA; Guidi, M; Marzolini, C; Stader, F; Stoeckle, M | 1 |
| Chetty, M; De Sousa Mendes, M | 1 |
| Bai, X; Hao, Y; Li, M; Lu, Z; Tang, Q; Wang, Y; Zhang, J; Zhang, Q; Zhao, J | 1 |
| Arendt, G; Orhan, E; Schlonies, S; Stüve, O | 1 |
| Adney, EM; Ambati, J; Ambati, K; Beauséjour, C; Boeke, JD; Brocculi, G; Caligiana, A; Criscione, SW; De Cecco, M; Elias, AE; Gorbunova, V; Helfand, SL; Ito, T; Le, O; Neretti, N; Petrashen, AP; Sedivy, JM; Seluanov, A; Simon, M; Skvir, NJ; Slagboom, PE | 1 |
| Changchien, CS; Chen, CH; Hsu, MC; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH; Yao, CC | 1 |
| Capparelli, EV; Chokephaibulkit, K; Cressey, TR; McKinney, R; Mirochnick, M; Nikanjam, M; Tremoulet, AH | 1 |
| Armishaw, J; Cameron, PU; Chuah, J; Cooper, DA; Crowe, SM; Fairley, C; Gouillou, M; Hearps, A; Koelsch, KK; Leeansyah, E; Lewin, SR; Liu, JP; Pierce, AB; Smit, de V; Solomon, A; Spelman, T; Tennakoon, S; Velayudham, P | 1 |
| Choi, MH; Chung, YH; Jang, MK; Kim, JA; Lee, HC; Lee, YS; Park, NH; Ryu, SH; Shin, JW; Suh, DJ | 1 |
| Chien, RN; Chu, CM; Liaw, YF; Tsai, SL; Yeh, CT | 1 |
| Bergshoeff, AS; Burger, DM; de Groot, R; Gibb, DM; Green, H; Hartwig, NG; La Porte, CJ; Lyall, H; Rakhmanina, N; Soldin, S; Verweel, G; Verwey-Van Wissen, CP | 1 |
1 trial(s) available for lamivudine and Aging
| Article | Year |
|---|---|
Developmental pharmacokinetic changes of Lamivudine in infants and children.
Topics: Adolescent; Age Factors; Aging; Anti-HIV Agents; Area Under Curve; Child; Child, Preschool; Creatinine; HIV Infections; Humans; Infant; Infant, Newborn; Lamivudine; Models, Biological; Reverse Transcriptase Inhibitors | 2012 |
10 other study(ies) available for lamivudine and Aging
| Article | Year |
|---|---|
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.
Topics: Aged; Aged, 80 and over; Aging; Anti-HIV Agents; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Prospective Studies; Pyridones; Viral Load | 2020 |
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment.
Topics: Adult; Aged; Aging; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Emtricitabine; Humans; Kidney Diseases; Kidney Function Tests; Lamivudine; Middle Aged; Models, Biological; Predictive Value of Tests; Tenofovir; Young Adult | 2019 |
Lamivudine improves cognitive decline in SAMP8 mice: Integrating in vivo pharmacological evaluation and network pharmacology.
Topics: Aging; Animals; Cognition; Cognitive Dysfunction; Lamivudine; Male; Mice; Neurodegenerative Diseases; Reverse Transcriptase Inhibitors | 2021 |
Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.
Topics: Adult; Aging; Antiretroviral Therapy, Highly Active; Brain; Cognition; Cognitive Dysfunction; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir | 2019 |
L1 drives IFN in senescent cells and promotes age-associated inflammation.
Topics: Aging; Animals; Cellular Senescence; Down-Regulation; Female; Fibroblasts; Humans; Inflammation; Interferon Type I; Lamivudine; Long Interspersed Nucleotide Elements; Male; Mice; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 2019 |
Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.
Topics: Adult; Aging; Antiviral Agents; Consolidation Chemotherapy; Female; Follow-Up Studies; Forecasting; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleotides; Recurrence; Retrospective Studies; Risk; Seroconversion; Time Factors; Young Adult | 2015 |
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
Topics: Adenine; Adult; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cells, Cultured; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Enzyme Activation; Female; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Regression Analysis; Reverse Transcriptase Inhibitors; Risk Factors; Telomerase; Telomere; Telomere Shortening; Tenofovir; Time Factors; Young Adult; Zidovudine | 2013 |
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study.
Topics: Adult; Aging; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Prognosis; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Core Proteins | 2003 |
Determinants for sustained HBeAg response to lamivudine therapy.
Topics: Adult; Aging; Drug Administration Schedule; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Logistic Models; Male; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Age-dependent pharmacokinetics of lamivudine in HIV-infected children.
Topics: Aging; Algorithms; Anti-HIV Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Female; HIV Infections; Humans; Lamivudine; Male; Sex Characteristics | 2007 |